Drug-coated Balloons Market Size, Share and Trends Analysis Report 2024-2031

InsightAce Analytic announces the release of a market assessment report on the "Global Drug-coated Balloons Market- by Product (Drug-Coated Balloons for Peripheral Artery Disease, Drug-Coated Balloons for Coronary Artery Disease and Drug-Coated Balloons for Other Indications), End User (Hospitals, Cardiac Catherization Labs and Ambulatory Surgical Centers), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

The Drug-coated Balloons Market Size is valued at 594.0 million in 2022 and is predicted to reach 1301.8 million by the year 2031 at a 9.2 % CAGR during the forecast period for 2023-2031.

Get A Free Report Brochure: https://www.insightaceanalytic.com/request-sample/1099

Drug-coated balloons are semi-compliant angioplasty balloons treated with cytotoxic chemotherapeutic agents (DCB). Paclitaxel-coated balloons are being utilized more frequently in commercial contexts. A novel approach, drug-coated balloons, has been developed in recent years to address the deficiencies of drug-coated stents. They are anticipated to be effective in subgroups that are difficult to treat. The number of drug-coated balloons discovered for coronary and peripheral purposes was recently calculated through preclinical and clinical investigations, with promising results.

The global market for drug-coated balloons is anticipated to be stimulated by the growing interest in minimally invasive surgery and the advancement of technology. The market is significantly impacted by the increasing prevalence of peripheral and coronary artery issues on a global scale. The market expansion is further fueled by the rapidly expanding geriatric population with cardiovascular diseases, the enormous patient base in developing countries, and cumulative investments in research and development for the treatment of peripheral and coronary artery problems. Due to the stringent regulatory restrictions and the high cost of procedures and materials, the global market for drug-coated balloons is anticipated to expand incrementally. It is expected that North America will contribute to the drug-coated balloon market.

Order this Premium Report: https://www.insightaceanalytic.com/buy-report/1099

The high market share is primarily due to the increased availability of treatment options and the prevalence of a significant disease population. Due to the availability of a multitude of clinical evidence, the approval of new products, the expansion of indication approvals for commercially existing DCBs, and the approval of new products, the North American market is anticipated to experience profitable growth during the projection period. Furthermore, the Asia Pacific Drug-coated Balloons market is anticipated to experience substantial growth as a result of the ageing population, the growing demand for higher-quality healthcare, and the increasing prevalence of cardiovascular diseases. In China, the ageing population is contributing to an increase in cardiovascular ailments and disorders.

Major market players operating in the Drug-coated Balloons market include
AR Baltic Medical, Acrostak, Biosensors International Group, Cardionovum, Concept Medical, ENDOCOR, Hexacath, iVascular SLU, M.A. Med Alliance, Minvasys, Orchestra BioMed, QT Vascular, Medtronic, BD, Koninklijke Philips, B. Braun Melsungen, BIOTRONIK, Boston Scientific, Opto Circuits (India), Acotec Scientific, RD Global-Invamed, Surmodics, Terumo, Welling, and Other prominent players.

Recent collaborations and agreements in the market:
• In May 2022, FDA approval for the investigational device exemption was granted to MedAlliance's SELUTION SLR Drug-eluting Balloon. SELUTION SLR (Sustained Limus Release), a novel sirolimus-eluting balloon, provides a regulated and sustained drug release, similar to that of a drug-eluting stent.
• In June 2020, Essential Pro, a revolutionary coronary artery drug-coated balloon, was introduced by iVascular SLU on a global scale (DCB). In numerous respects, the Essential Pro DCB surpasses its predecessor, such as the availability of two distinct shaft options, an extension of the inflating channel, and superior safety. Additionally, it offers fast deflation times.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1099

Market Segments
Global Drug-coated Balloons Market, by End User, 2022-2028 (Value US$ Mn)
• Hospitals
• Cardiac Catheterization Labs
• Ambulatory Surgical Centers
Global Drug-coated Balloons Market, by Product, 2022-2028 (Value US$ Mn)
• Drug-Coated Balloons for Peripheral Artery Disease
• Drug-Coated Balloons for Coronary Artery Disease
• Drug-Coated Balloons for Other Indications
Global Drug-coated Balloons Market, by Region, 2022-2028 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• U.S.
• Canada
Europe Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
> To acquire a thorough examination of the global Drug-coated Balloons market's prospects
> To obtain an industry overview and future trends of the Drug-coated Balloons market
> To conduct an analysis of the market drivers and challenges for drug-coated balloons
> To obtain information regarding the market value of drug-coated balloons in the United States (US$ Mn) through 2028
> The Drug-coated Balloons market has experienced substantial investments, mergers, and acquisitions.

Details insights on this market: https://www.insightaceanalytic.com/report/global-drug-coated-balloons-market-/1099

Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email: info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.